The remarkable advances coming about through nanotechnology promise to revolutionize
many aspects of modern life; however, these advances come with a responsibility for due …

The prevalence of neurological/neurodegenerative diseases, such as Alzheimer's disease is
known to be increasing due to an aging population and is anticipated to further grow in the …

Advances in nanotechnology have enabled the design of nanotherapeutic platforms that
could address the challenges of targeted delivery of active therapeutic agents to the central …

With the development of nanotechnology, metal‐containing nanoparticles are used widely in
the diagnosis, monitoring and treatment of central nervous system (CNS) diseases. The …

Nanoparticles (NPs) that target multiple transport mechanisms facilitate targeted delivery of
active therapeutic agents to the central nervous system (CNS) and improve therapeutic …

Nanoparticles (NPs) are generally defined as very small particles in the size range of 1-100
nm. Due to the rapid development of modern society, many new materials have been …

Silver nanoparticles (AgNPs) have been incorporated in many consumer and biomedical
products. Serious concerns have been expressed about the environmental and public …

Alzheimer's disease (AD) is one of the chief neurological difficulties in the aged population,
identified through dementia, memory disturbance, and reduced cognitive abilities. β‐amyloid …

The presence of the blood–brain barrier (BBB) limit gold nanoparticles (GNP) accumulation
in central nervous system (CNS) after intravenous (IV) administration. The intranasal (IN) …

As the release of silver nanoparticles (AgNPs) in the environment continues to increase,
great concerns have been raised about their potential toxicity to humans. It is urgent to …